A national multidisciplinary group of diabetes experts who launched a new set of recommendations last year on how to manage diabetes in older adults in care homes has had its interim findings published.
The National Advisory Panel for Care Home Diabetes (NAPCHD) – which is chaired by Professor Alan Sinclair – has partnered with some of the industry’s top healthcare professionals to develop this national Strategic Document of Diabetes Care for Care Homes.
The National Paediatric Diabetes Audit (NPDA) has published a new report on the care and outcomes of children and young people living with the condition in 2021/22.
According to the new document, there was an increase in incidence of type 1 diabetes in the first year of the COVID-19 pandemic, followed by a continuing rise in the numbers of newly diagnosed children and young people with the condition in 2021/22.
Updated guidance on how finerenone can treat chronic kidney disease in people with type 2 diabetes will be published next week by the National Institute for Health and Care Excellence.
This new guideline will appraise the clinical and cost effectiveness of finerenone within its marketing authorisation for treating chronic kidney disease in people living with type 2 diabetes.
Vitamin B12 deficiency is an independent predictor of diabetic gastroparesis in people with type 2 diabetes, latest evidence reveals.
The study was conducted by a team of researchers wanting to explore the possible association between vitamin B12 deficiency and gastroparesis in people with type 2 diabetes.
More than 70 per cent of people living with diabetes believe that advanced insulin delivery systems are ‘very useful’ in helping them manage their condition, latest research indicates. To read more, click here.
Individuals with type 2 diabetes are more likely to develop breast and bowel cancers compared to people living without the condition, latest evidence reveals. To read more, click here.
People with high blood sugar levels are less likely to develop type 2 diabetes if they attend an NHS behaviour-change programme. To read more, click here.
The Type 1 Diabetes Grand Challenge has announced funding of three major research projects. To read more, click here.
A tech company developing the world’s first non-invasive wearable blood glucose sensor has been hailed as an “innovation success story” by the Wales Director of the CBI.
Ian Price said Afon Technology, based in Caldicot, was boosting economic growth in the country by creating high-skilled jobs with its pursuit of creating the holy grail of diabetes monitoring.
People intolerant to statins who are being treated with bempedoic acid are less at risk of experiencing a major adverse cardiovascular event, latest evidence claims. To read more, click here.
PolyPhotonix Limited and embecta UK have signed a co-promotional agreement under which embecta will promote PolyPhotonix’s Noctura 400 Sleep Mask to healthcare professionals. To read more, click here.
It eventually comes to that point where you decide whether you become part of a system which won't do what's needed. How far you compromise, and at what point do you continue the battle but in a different manner. My last blog on this issue of my experiences while doing the work tackling racism was clear, and no one has asked it to be taken down, challenged me or any of that. Simply because those involved know they are true. To read more, click here.
Bringing you the latest jobs from around the country within the field of diabetes.
Paediatric Diabetes Dietitian – East Kent Hospitals University NHS Foundation Trust
Specialist Diabetes Dietitian – King's College Hospital NHS Foundation Trust
Diabetes Specialist Nurse – Northern Care Alliance NHS Foundation Trust
Consultant Physician in Diabetes & Endocrinology – The Mid Yorkshire Hospitals NHS Trust
With thanks to our sponsors
Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.
We are now on YouTube where you will find interviews with leading figures within the field of diabetes. Click here to visit our page.
